Keyphrases
Denmark
100%
8-oxoguanine
86%
Type 2 Diabetes Mellitus (T2DM)
73%
Oxidative Stress
60%
Confidence Interval
57%
Oxidative DNA Damage
51%
Type 2 Diabetic Patients
47%
8-oxo-7,8-dihydroguanosine
45%
Placebo
42%
National Cohort Study
41%
Paracetamol
41%
Glucagon-like
41%
Glucose-dependent Insulinotropic Polypeptide
41%
Pharmacokinetics
37%
Urinary Excretion
35%
Antipyrine
34%
Metabolism
28%
RNA Oxidation
27%
N-acetylcysteine
27%
Odds Ratio
26%
Acetaminophen
26%
During Pregnancy
26%
Poisoning
25%
Randomized Clinical Trial
25%
Oxidative Stress Markers
24%
Liver
24%
DNA Damage
22%
Paracetamol Overdose
22%
Randomized Controlled Trial
21%
Metformin
21%
Placebo-controlled
21%
Randomized Placebo-controlled Trial
20%
Randomized Double-blind
20%
Meta-analysis
20%
Polypharmacy
20%
Glucagon
19%
Hemoglobin A1c (HbA1c)
19%
Antipsychotics
19%
Poison Control Centers
19%
Capital Region
19%
Hazard Ratio
19%
Vitamin C
18%
DNA Oxidation
18%
Adverse Events
17%
Medication Review
17%
RNA Damage
17%
A1 Receptor
17%
Vitamin E
17%
Randomized Trial
17%
Healthy Individuals
16%
Metronidazole
16%
High Dose
16%
Smokers
16%
Blood Pressure
16%
COVID-19
15%
Adverse Effects
15%
Hospitalized Patients
15%
Glucose-lowering Drugs
15%
Urinary Markers
15%
Plasma Concentration
15%
Cytochrome P450 1A2 (CYP1A2)
14%
Type 1 Diabetes Mellitus (T1DM)
14%
Antioxidant
14%
Polymorphism
14%
Glutathione
14%
Ascorbic Acid
14%
Adverse Drug Reaction
14%
Nucleic Acid Oxidation
13%
Glucose-dependent Insulinotropic Polypeptide Receptor
13%
Hospitalization
13%
Type I Diabetes
13%
DNA Repair
12%
Copenhagen
12%
Healthy Controls
12%
Systematic Meta-analysis
12%
Register-based
12%
Blood Samples
12%
Oxidative Damage
12%
Obesity
12%
Prescription Drugs
12%
Drug Interactions
12%
Rat Liver
12%
Colon
12%
Genotype
12%
Cytochrome P450 2D6 (CYP2D6)
12%
Selective Serotonin Reuptake Inhibitors
12%
Activated Charcoal
11%
Bipolar Disorder
11%
Receptor Agonist
11%
Liraglutide
11%
Register Study
11%
Medication Use
11%
Type 2 Diabetes Prevention
11%
Carboxylesterase 1 (CES1)
11%
Oxazepam
11%
No Significant Difference
11%
Gastric Emptying
11%
University Hospital
11%
Cystic Fibrosis
10%
Guanine
10%
Pharmacology, Toxicology and Pharmaceutical Science
Paracetamol
77%
Toxic Injury
74%
Non Insulin Dependent Diabetes Mellitus
74%
Cohort Study
69%
8 Hydroxydeoxyguanosine
65%
Placebo
62%
Pharmacokinetics
51%
Adverse Event
44%
Disease
39%
Biological Marker
30%
Gastric Inhibitory Polypeptide
29%
Ascorbic Acid
28%
Malignant Neoplasm
28%
Acetylcysteine
27%
Prevalence
24%
Phenazone
24%
Antioxidant
24%
Elimination
22%
Congenital Malformation
21%
Glutathione
20%
Nucleic Acid
20%
Poison Control Centers
20%
Glucagon-Like Peptide-1
19%
Pharmacotherapy
19%
Adverse Drug Reaction
19%
Mouse
18%
Normal Human
18%
Symptom
16%
Polypharmacy
16%
Side Effect
15%
Pharmacodynamics
15%
Typical Antipsychotic
14%
Metformin
14%
Randomized Controlled Trial
14%
Infection
14%
Cardiovascular Disease
14%
Drug Metabolism
13%
Hepatotoxicity
13%
Metronidazole
13%
Gastric Inhibitory Polypeptide Receptor
13%
Antipsychotic
12%
Creatinine
12%
Asthma
12%
CYP1A2
12%
Alpha Tocopherol
12%
Bile Acid
11%
Clinical Trial
11%
High Performance Liquid Chromatography
11%
Drug Information
11%
Guanosine
11%
Oxazepam
11%
Selective Serotonin Reuptake Inhibitor
11%
Chronic Obstructive Lung Disease
11%
Glucagon Like Peptide 1 Receptor Agonist
10%
Obesity
10%
CYP2D6
10%
Cystic Fibrosis
10%
Observational Study
10%
Analgesic Agent
9%
Guanine
9%
Isradipine
9%
Cytochrome
9%
Combination Therapy
9%
Deoxyguanosine
9%
Cytochrome P450
9%
Nucleoside
9%
CYP2C19
9%
Hemoglobin A1c
9%
Defined Daily Dose
9%
Heart Failure
9%
Spontaneous Abortion
9%
Metoprolol
9%
Receptor Antagonist
9%
Randomized Clinical Trial
9%
Tramadol
8%
Drug-Drug Interaction
8%
Coronavirinae
8%
Inflammation
8%
Methylphenidate
8%
Big Blue Rat
8%
Antidepressant
8%
Liraglutide
8%
Drug Screening
8%
Opiate
8%
Ischemic Heart Disease
8%
Genotoxicity
8%
Medication Error
8%
Reactive Oxygen Metabolite
7%
Fluvoxamine
7%
Benzodiazepine
7%
Antibiotic Agent
7%
Bioavailability
7%
Hydrocortisone
7%
Low Density Lipoprotein Cholesterol
7%
All Cause Mortality
7%
Cimetidine
7%
Activated Carbon
7%
Glucagon-Like Peptide 1 Receptor
7%
Liver Cirrhosis
7%
Antibiotics
7%
Medicine and Dentistry
Maturity Onset Diabetes of the Young
62%
Drug Therapy
40%
Cohort Analysis
39%
Placebo
35%
Gastric Inhibitory Polypeptide
29%
Glucagon Like Peptide 1
22%
Patient with Type 2 Diabetes
21%
Adverse Event
21%
Glycon
20%
Disease
20%
Oxidative Stress
20%
Systematic Review
17%
Randomized Clinical Trial
17%
Hazard Ratio
16%
Infusion
15%
Blood Pressure
15%
Diabetes
15%
8 Hydroxydeoxyguanosine
14%
Urinary System
14%
Cardiovascular Disease
13%
COVID-19
13%
Randomized Controlled Trial
13%
Meta-Analysis
13%
Malignant Neoplasm
12%
Urinary Excretion
12%
Biological Marker
11%
Medicine
11%
Hemoglobin A1c
11%
Ascorbic Acid
11%
DNA Damage
11%
Antioxidant
11%
Odds Ratio
10%
Lifestyle Intervention
10%
Supplementation
10%
Symptom
9%
Prevalence
9%
Body Mass Index
9%
Nucleic Acid
9%
Obesity
9%
Food Intake
9%
Cardiovascular System
9%
Paracetamol
9%
Glucagon
8%
DNA Repair
8%
Breast Cancer
8%
Post-Hoc Analysis
8%
Breast Implant
8%
Glucagon-Like Peptide-1 Agonist
8%
Glycemic Control
7%
Androgen
7%
Hypoglycemia
7%
Exercise
7%
Spontaneous Abortion
7%
Adolescent
7%
Antibiotics
7%
Adverse Drug Reaction
7%
Gut
7%
General Practitioner
7%
First Trimester Pregnancy
7%
Insulin Dependent Diabetes Mellitus
7%
Infection
7%
Anabolic Agent
7%
Childbirth
7%
Bile Acid
6%
Chronic Obstructive Pulmonary Disease
6%
Physical Activity
6%
Cosmetics
6%
Observational Study
6%
Body Weight
6%
Clinical Trial
6%
Receptor
6%
Arm
6%
Low Density Lipoprotein Cholesterol
6%
Sodium Glucose Cotransporter 2 Inhibitor
6%
Congenital Malformation
6%
Cross Sectional Study
6%
Opiate
6%
Glucose Metabolism
6%
Polypharmacy
6%
Secretion (Process)
6%
Sodium Intake
6%
Alpha Tocopherol
6%
Hydrocortisone
6%
Receptor Antagonist
6%
Emergency Department
5%
Incretin
5%
Diabetes Mellitus
5%
Health Care
5%
Intensive Care Unit
5%
Cystic Fibrosis
5%
Triacylglycerol
5%
Outpatient
5%
Cell Function
5%
Psoriasis
5%
Knee Arthroplasty
5%
Coronary Artery Disease
5%
Hip Arthroplasty
5%
B-Cell Chronic Lymphocytic Leukemia
5%
Ischemic Heart Disease
5%
Stomach Emptying
5%